ENLIE Pharmaceutical JSC (HSTC:BCP) Stock Based Compensation: ₫0.00 Mil (TTM As of . 20)


HSTC:BCP ENLIE Pharmaceutical JSC HSTC:BCP
25 GF Score
Price ₫10,000.00
View Full Analysis

What is ENLIE Pharmaceutical JSC Stock Based Compensation?

ENLIE Pharmaceutical JSC HSTC:BCP -5.66% 25 Stock Based Compensation is ₫0.00 Mil as of . 20. GuruFocus rates HSTC:BCP with a GF Score™ of 25/100.

ENLIE Pharmaceutical JSC's Stock Based Compensation for the six months ended in . 20 was ₫0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in . 20 was ₫0.00 Mil.

ENLIE Pharmaceutical JSC Stock Based Compensation Related Terms

ENLIE Pharmaceutical JSC Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for ENLIE Pharmaceutical JSC's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ENLIE Pharmaceutical JSC Stock Based Compensation Chart

ENLIE Pharmaceutical JSC Annual Data
Trend
Stock Based Compensation

ENLIE Pharmaceutical JSC Semi-Annual Data
Stock Based Compensation
HSTC:BCP
25GF Score
ENLIE Pharmaceutical JSC HSTC:BCP
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ENLIE Pharmaceutical JSC Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Stock Based Compensation for the trailing twelve months (TTM) ended in . 20 was ₫0.00 Mil.

What does a Stock Based Compensation of ₫0.00 Mil mean?
ENLIE Pharmaceutical JSC (HSTC:BCP) has a Stock Based Compensation of ₫0.00 Mil as of . 20. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for ENLIE Pharmaceutical JSC and its competitors.
Is ENLIE Pharmaceutical JSC's Stock Based Compensation too high?
ENLIE Pharmaceutical JSC's current Stock Based Compensation is ₫0.00 Mil. Overall, ENLIE Pharmaceutical JSC has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does ENLIE Pharmaceutical JSC's Stock Based Compensation compare to ?
ENLIE Pharmaceutical JSC's Stock Based Compensation of ₫0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Drug Manufacturers company?
A good Stock Based Compensation depends on the Drug Manufacturers industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for ENLIE Pharmaceutical JSC and its competitors. ENLIE Pharmaceutical JSC's current Stock Based Compensation is ₫0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ENLIE Pharmaceutical JSC stock overvalued right now?
ENLIE Pharmaceutical JSC (HSTC:BCP) has a current Stock Based Compensation of ₫0.00 Mil. The current Stock Based Compensation is ₫0.00 Mil. ENLIE Pharmaceutical JSC's overall GF Score™ is 25/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For ENLIE Pharmaceutical JSC (HSTC:BCP), the current Stock Based Compensation is ₫0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ENLIE Pharmaceutical JSC Business Description

Comparable Companies
Address NA6 Street, My Phuoc 2 Industrial Park, Ben Cat district, Binh Duong, VNM
ENLIE Pharmaceutical JSC is engaged in the production and trading of pharmaceuticals, medical supplies, cosmetics, foods, and functional foods. It is also engaged in the wholesale of other installation materials and equipment in the construction.
25GF Score

Get the complete analysis for HSTC:BCP

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫10,000.00
Price